Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction: A randomized controlled trial

Cardiology

Volumn 106, Issue 4, 2006, Pages 215-223

  Tarantini, Giuseppe ^a,e   Scrutinio, Domenico ^b   Bruzzi, Paolo ^c   Boni, Luca ^c   Rizzon, Paolo ^d   Iliceto, Sabino ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF BARI   (Italy)

^e UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Acute myocardial infarction; Myocardial infarction, treatment; Pharmacology, cardiovascular

Indexed keywords

CARNITINE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CARNITINE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 33751098827     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093131     Document Type: Article

References (29)

1. Armstrong PW, Collen D: Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion. Part I. Circulation 2001;103;2862-2866.
2. Armstrong PW, Collen D: Fibrinolysis for acute myocardial infarction. Current status and new horizons for pharmacological reperfusion. Part II. Circulation 2001;103;2987-2992.
3. Topol EJ: Current status and future prospects for acute myocardial infarction therapy. Circulation 2003;108(suppl 1):III6-III13.
4. Boersma E, Mercado N, Poldermans D, Gardien M, Vos J, Simoons ML: Acute myocardial infarction. Lancet 2003;361:847-858.
5. Opie LH: Proof that glucose-insulin-potassium provides metabolic protection of ischemic myocardium? Lancet 1999;353:768-769.
6. Apstein CS: Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury. Am Heart J 2000;139:S107-S114.
7. Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Circulation 1997;96:1152-1156.
8. van der Horst IC, Zijlstra F, van't Hof AWJ, Doggen CJ, de Boer MJ, Suryapranata H, Hoorntje JC, Dambrik JHE, Gans RJB, Bilo HJG; and Zwolle Infarct Study Group: Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. The glucose-insulin- potassium study: a randomized trial. J Am Coll Cardiol 2003;42:784-791.
9. Opie LH: Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J 1979;97:375-388.
10. Spagnoli LG, Corsi M, Villaschi S, Palmieri G, Maccari F: Myocardial carnitine deficiency in acute myocardial infarction. Lancet 1982;1:1419-1420.
11. Fujiwara M, Nakano T, Tamato S, Yamada Y, Fukai M, Takada K, Ashida H, Shimada T, Ishihara T, Seki I: Effects of L-carnitine in patients with ischemic heart disease. Am J Cardiol 1991;21:493-504.
12. Lopaschuk G: Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 2000;139:S115-S119.
13. Lango R, Smolenski RT, Narkiewicz M, Suchorzewska J, Lysiak-Szydlowska W: Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary by-pass. Cardiovasc Res 2001;51:21-29.
14. Arsenian MA: Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 1997;40:265-286.
15. Rodgers RL, Christie ME, Tremblay GC, Babson JR, Daniels T: Insulin-like effects of a physiologic concentration of carnitine on cardiac metabolism. Mol Cell Biochem 2001;226:97-105.
16. Cui J, Das DK, Bertelli A, Tosaki A: Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. Mol Cell Biochem 2003;254:227-234.
17. Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, Di Biase M, Biasco G, Hugenholtz PG, Rizzon P: Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial. J Am Coll Cardiol 1995;26:380-387.
18. Kober L, Torp-Pedersen C: Clinical characteristics and mortality of patients screened for entry into the Trandolapril Cardiac Evaluation (TRACE) study. Am J Cardiol 1995;76:1-5.
19. Andersen PK: Conditional power calculations as an aid in the decision whether to continue a clinical trial. Control Clin Trials 1987;8:67-74.
20. Reimer KA, Heide RSV, Richard VJ: Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models. Am J Cardiol 1993;72:13G-21G.
21. Raitt MH, Maynard C, Wagner GS, Wagner GS, Cerqueira MD, Selvester RH, Wever WD: Relation between symptom duration before thrombolytic therapy and final infarct size. Circulation 1996;93:48-53.
22. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ: Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
23. Lee L, Horowitz J, Frenneaux M: Metabolic manipulation in ischaemic heart disease, a novel approach to treatment. Eur Heart J 2004;25:634-641.
24. Reffelmann T, Hale SL, Li G, Kloner RA: Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2002;282:H766-H772.
25. Carvajal K, Moreno-Sanchez R: Heart metabolic disturbances in cardiovascular disease. Arch Med Res 2003;34:89-99.
26. Ura K, Hironaka Y Sakurai I: Effect of carnitine on size limitation of experimental myocardial infarct. Am J Cardiovasc Pathol 1990;3:131-142.
27. Liedtke AJ, Demaison L, Nellis SH: Effects of L-propionyl-L-carnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 1988;255:H169-H176.
28. Micheletti R, Di Paola E, Schiavone A, English E, Benati P, Capoasso JM, Anversa P, Bianchi G: Propionyl-L-carnitine limits chronic ventricular dilatation after myocardial infarction in rats. Am J Physiol 1993;264:H1111-H1117.
29. Beyersdorf F, Acar C, Buckberg GD, Partington MT, Okamoto F, Allen BS, Young HH, Bugyi HI: Studies on prolonged acute regional ischemia. V. Metabolic support of remote myocardium during left ventricular power failure. J Thorac Cardiovasc Surg 1989;98:567-579.